Cycling of Sedative Infusions in Critically Ill Pediatric Patients
Respiratory Failure
About this trial
This is an interventional treatment trial for Respiratory Failure focused on measuring Sedation, Cycling, Pediatric
Eligibility Criteria
Inclusion Criteria:
- Less than or equal to 18 years of age
- Intubated and mechanically ventilated
- Expected to require continuous infusions of sedatives for at least 48 hours
- Parent or legal guardian available for informed consent
- Males and females of any race are eligible
Exclusion Criteria:
- Less than 72 hours after surgery
- Cyanotic heart disease with unrepaired or palliated right to left intracardiac shunt
- Critical airway (according to PICU Attending)
- Ventilator dependent (including noninvasive) on PICU admission
- Greater than 48 hours of continuous sedation infusion(s)
- Neuromuscular respiratory failure
- Managed by patient controlled analgesia (PCA) or epidural catheter
- Known allergy to any of the study medications (fentanyl or midazolam)
- Family/Medical team have decided not to provide full support (patient treatment considered futile)
- Patient requires ECMO
- Head trauma requiring intracranial pressure monitoring
- Pregnancy
- Following resuscitation from cardiorespiratory arrest whose initial pH is < 6.9
- ICU Attending judgment that patient should be excluded for safety reasons
Sites / Locations
- Cook Children's Medical Center
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Experimental Group
Control Group
In this arm Fentanyl and Midazolam was replaced with placebo (normal saline) during cycling. At cycling time for midazolam, the continuous infusion of midazolam was stopped by the bedside nurse. The nurse started a pump containing a syringe labeled "Study Drug M" which contained the placebo drug (normal saline). The switch to Study Drug M occurred twice daily at 0800 and 2000 for a period of 3 hours each. At cycling time for fentanyl, the continuous infusion of fentanyl was stopped by the bedside nurse. The pump containing a syringe labeled "Study Drug F," which contained the placebo drug (normal saline), was started. The switch Study Drug F occurred twice daily at 1400 and 0200 for a period of 3 hours each. Dosing was done per standard of care and not prescribed per protocol
In this arm, midazolam and fentanyl were administered during cycling. At cycling time for midazolam, the continuous infusion of midazolam was stopped by the bedside nurse. The nurse started a pump containing a syringe labeled "Study Drug M" which contained the control drug (midazolam). The switch to Study Drug M occurred twice daily at 0800 and 2000 for a period of 3 hours each. At cycling time for fentanyl, the continuous infusion of fentanyl was stopped by the bedside nurse. The pump containing a syringe labeled "Study Drug F," which contained the control drug (fentanyl), was started. The switch to Study Drug F occurred twice daily at 1400 and 0200 for a period of 3 hours each. Dosing was done per standard of care and not prescribed per protocol.